QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Tevogen Bio Holdings Inc. ("Tevogen" or "Tevogen Bio") (NASDAQ:TVGN), a clinical-stage specialty immunotherapy ...

Core News & Articles

Tevogen Bio Holdings (NASDAQ:TVGN) reported quarterly losses of $(0.04) per share. This is a 77.78 percent increase over losses...

Core News & Articles

Tevogen Bio Holdings Inc. ("Tevogen" or "Tevogen Bio") (NASDAQ:TVGN), a clinical-stage specialty immunotherapy ...

Core News & Articles

Tevogen Bio Holding Inc. ("Tevogen" or "Tevogen Bio") (NASDAQ:TVGN), a clinical-stage specialty immunotherapy b...

Core News & Articles

Dr. Flomenberg and Dr. Grosso are leading experts in T cell biology and its clinical applicationsTevogen's ExacTcell™ platf...

Core News & Articles

Interventional arm patients, totaling twelve high-risk individuals, 50% of whom were immunocompromised, and 40% of whom were im...

Core News & Articles

Tevogen Bio Holdings Inc. ("Tevogen" or "Tevogen Bio") (NASDAQ:TVGN), a clinical-stage specialty immunotherapy ...

Core News & Articles

Includes $36 million line of credit and potential $14 million private placement WARREN, N.J., June 11, 2024 (GLOBE NEWSWIRE) --...

Core News & Articles

Tevogen Bio Holdings Inc. ("Tevogen" or "Tevogen Bio") (NASDAQ:TVGN), a clinical-stage specialty immunotherapy ...

Core News & Articles

Tevogen Bio Holdings (NASDAQ:TVGN) reported quarterly losses of $(0.26) per share. This is unchanged from the same period last ...

 why-tevogen-bio-holdings-stock-is-moving-higher-today

Tevogen shares are rising Monday after the company secured up to $50 million of financing from an existing investor aimed at su...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION